Vol. 29 No. 3 (2025): Patologiya krovoobrashcheniya i kardiokhirurgiya
CARDIOLOGY

Predictors of the development of residual pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension

Oksana Ya. Vasiltseva
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Devran F. Zeinalov
Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
Alexander G. Edemskiy
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Alexey G. Lavrov
LLC “NovInTech”
Denis S. Grankin
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Dmitry A. Sirota
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation
Aleksandr M. Chernyavskiy
Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Published 2025-12-18

Keywords

  • pulmonary endarterectomy; chronic thromboembolic pulmonary hypertension; residual pulmonary hypertension; predictors of residual pulmonary hypertension; modifiable and non-modifiable predictors

How to Cite

Vasiltseva, O. Y., Zeinalov, D. F., Edemskiy, A. G., Lavrov, A. G., Grankin, D. S., Sirota, D. A., & Chernyavskiy, A. M. (2025). Predictors of the development of residual pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 29(3), 5–17. https://doi.org/10.21688/1681-3472-2025-3-5-17

Abstract

Introduction. After pulmonary endarterectomy (PEA), a third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) develop residual pulmonary hypertension (PH) in the postoperative period, which plays a decisive role in the formation of long-term mortality, but in modern clinical practice there are no tools for predicting its probability.

Objective. of the study was to determine predictors of residual pulmonary hypertension after pulmonary endarterectomy.

Methods. The retrospective cohort observational study included 353 patients aged 19 to 77 years with CTEPH who underwent PEA at the Federal State Budgetary Institution "National Medical Research Center named after Academician E.N. Meshalkin" from 2004 to 2019. The patients underwent clinical and instrumental examination before PEA, after PEA during the hospital period and in the late period (12 months) after PEA. An analysis of the obtained factors was carried out, non-modifiable and modifiable predictors of residual PH were determined.

Results. According to the regression analysis, independent non-modifiable predictors of residual PH after PEA were identified: history of cancer; blood group AB (IV); reperfusion syndrome after PEA; pulmonary vascular resistance >1000 dyn×s×cm–5 according to pulmonary circulation tensiometry data before PEA; the ratio of the systolic excursion of the tricuspid valve annulus to the systolic pressure in the pulmonary artery <0,154 mm/mmHg before and after PEA and systolic pressure in the right ventricle >50 mmHg after PEA, measured by transthoracic echocardiography during the hospital period; thrombus calcification in the biopsy material of thrombotic masses. In addition, modifiable predictors were identified - delay in diagnosis and treatment of 6 months or more; obesity; smoking; anemia; irregular warfarin intake; failure to achieve target INR values; thrombosis of veins of any localization after LEE in dynamics.

Conclusion. For the first time in Russia, modifiable and non-modifiable predictors of residual PH after PEA in patients with CTEPH were identified. An optimization algorithm for early diagnosis and treatment of CTEPH was proposed.

 

References

  1. SimonneauG.,TorbickiA.,DorfmüllerP.,KimN.Thepathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160112. PMID: 28356405; PMCID: PMC9488693. https://doi.org/10.1183/16000617.0112-2016
  2. Kim N.H., Delcroix M., Jais X., Madani M.M., Matsubara H., Mayer E., Ogo T., Tapson V.F., Ghofrani H.A., Jenkins D.P. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1):1801915. PMID: 30545969; PMCID: PMC6351341. https://doi.org/10.1183/13993003.01915-2018
  3. Ruaro B., Baratella E., Caforio G., Confalonieri P., Wade B., Marrocchio C., Geri P., Pozzan R., Andrisano A.G., Cova M.A., Cortale M., Confalonieri M., Salton F. Chronic thromboembolic pulmonary hypertension: an update. Diagnostics. 2022;12(2):235. PMID: 35204326; PMCID: PMC8871284. https://doi.org/10.3390/diagnostics12020235
  4. Ende-Verhaar Y.M., Cannegieter S.C., Noordegraaf A.V., Delcroix M., Pruszczyk P., Mairuhu A.T., Huisman M.V., Klok F.A. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49(2):1601792. PMID: 28232411. https://doi.org/10.1183/13993003.01792-2016
  5. Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.P., Huisman M.V., Humbert M., Jennings C.S., Jiménez D., Kucher N., Lang I.M., Lorusso R., Mazzolai L., Meneveau N., Áinle F.N., Prandoni P., Pruszczyk P., Righini M., Torbicki A., Van Belle E., Zamorano J.L., ESC Scientific Document Group[Corporate Author]. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. PMID: 31504429. https://doi.org/10.1093/eurheartj/ehz405
  6. Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., Carlsen J., Coats A.J.S., Escribano- Subias P., Ferrari P., Ferreira D.S., Ghofrani H.A., Giannakoulas G., Kiely D.G., Mayer E., Meszaros G., Nagavci B., Olsson K.M., Pepke-Zaba J., Quint J.K., Rådegran G., Simonneau G., Sitbon O., Tonia T., Toshner M., Vachiery J.L., Vonk Noordegraaf A., Delcroix M., Rosenkranz S. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN- LUNG). Eur Heart J. 022;43(38):3618-3731. PMID: 36017548. https://doi.org/10.1093/eurheartj/ehac237
  7. Васильцева О.Я., Ворожцова И.Н., Лавров А.Г., Карпов Р.С. Оцен- ка факторов неблагоприятного прогноза у пациентов с тром- боэмболией легочной артерии. Терапевтический архив. 2016;12:28-33. https://doi.org/10.17116/terarkh2016881228-32 Vasil’tseva O.Ia., Vorozhtsova I.N., Lavrov A.G., Karpov R.S. Estima- tion of poor prognostic factors in patients with pulmonary ar- tery thromboembolism. Therapeutic Archive. 2016;88(12):28-32. (In Russ.) https://doi.org/10.17116/terarkh2016881228-32
  8. Delcroix M., Torbicki A., Gopalan D., Sitbon O., Klok F.A., Lang I., Jenkins D., Kim N.H., Humbert M., Jais X., Vonk Noordegraaf A., Pepke-Zaba J., Brénot P., Dorfmuller P., Fadel E., Ghofrani H.A., Ho- eper M.M., Jansa P., Madani M., Matsubara H., Ogo T., Grünig E., D’Armini A., Galie N., Meyer B., Corkery P., Meszaros G., Mayer E., Simonneau G. ERS statement on chronic thromboembolic pul- monary hypertension. Eur Respir J. 2021;57(6):2002828. PMID: 33334946. https://doi.org/10.1183/13993003.02828-2020
  9. Wilkens H., Konstantinides S., Lang I.M., Bunck A.C., Gerges M., Gerhardt F., Grgic A., Grohé C., Guth S., Held M., Hinrichs J.B., Hoeper M.M., Klepetko W., Kramm T., Krüger U., Lankeit M., Meyer B.C., Olsson K.O., Schäfers H.J., Schmidt M., Seyfarth H.J., Ulrich S., Wiedenroth C.B., Mayer E. Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:69-78. PMID: 30195840. https://doi.org/10.1016/j.ijcard.2018.08.079
  10. Васильцева О.Я., Едемский А.Г., Гранкин Д.С., Кливер Е.Н., Чернявский А.М. Путь от тромбоэмболии легочной артерии к хронической тромбоэмболической легочной гипертензии: факторы риска. Патология кровообращения и кардиохирургия. 2021;25(3):11-19. https://doi.org/10.21688/1681-3472-2021-3-11-19 Vasiltseva O.Ya., Edemskiy A.G., Grankin D.S., Kliver E.N., Chernyavskiy A.M. From pulmonary embolism to chronic thromboembolic pulmonary hypertension: risk factors. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2021;25(3):11-19. (In Russ.) https://doi.org/10.21688/1681-3472-2021-3-11-19
  11. Авдеев С.Н., Барбараш О.Л., Баутин А.Е., Волков А.В., Веселова Т.Н., Галявич А.С., Гончарова Н.С., Горбачевский С.В., Данилов Н.М., Еременко А.А., Мартынюк Т.В., Моисеева О.М., Саидова М.А., Сергиенко В.Б., Симакова М.А., Стукалова О.В., Чазова И.Е., Чернявский А.М., Шалаев С.В., Шмальц А.А., Царева Н.А. Легочная гипертензия, в том числе хроническая тромбоэмболическая легочная гипертензия. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;(12):4683. https://doi.org/10.15829/1560-4071-2021-4683 Avdeev S.N., Barbarash O.L., Bautin A.E., Volkov A.V., Veselova T.N., Galyavich A.S., Goncharova N.S., Gorbachevsky S.V., Danilov N.M., Eremenko A.A., Martynyuk T.V., Moiseeva O.M., Saidova M.A., Sergienko V.B., Simakova M.A., Stukalova O.V., Chazova I.E., Chernyavsky A.M., Shalaev S.V., Shmalts A.A., Tsareva N.A. 2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2021;26(12):4683. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4683
  12. Delcroix M., Lang I., Pepke‐Zaba J., Jansa P., D’Armini A.M., Snij- der R., Bresser P., Torbicki A., Mellemkjaer S., Lewczuk L., Simko- va I., Barberà J.A., de Perrot M., Hoeper M.M., Gaine S., Speich R., Gomez‐Sanchez M.A., Kovacs G., Jaïs X., Ambroz D., Treacy C., Morsolini M., Jenkins D., Lindner J., Dartevelle P., Mayer E., Simonneau G. Long‐term outcome of patients with chronic thrombo- embolic pulmonary hypertension: results from an international prospective registry. Circulation. 2016;133(9):859-71. PMID: 26826181. https://doi.org/10.1161/circulationaha.115.016522
  13. Чазова И.Е., Архипова О.А., Мартынюк Т.В. Легочная артериальная гипертензия в России: анализ шестилетнего наблюдения по данным Национального регистра. Терапевтический архив. 2019;91(1):24-31. https://doi.org/10.26442/00403660.2019.01.000024 Chazova I.E., Arkhipova O.A., Martynyuk T.V. Pulmonary arterial hypertension in Russia: six-year observation analysis of theNational Registry. Therapeutic Archive. 2019;91(1):24-31. (In Russ.) https://doi.org/10.26442/00403660.2019.01.000024
  14. de Perrot M., Thenganatt J., McRae K., Moric J., Mercier O., Pierre A., Mak S., Granton J. Pulmonary endarterectomy in severe chronic thromboembolic pulmonary hypertension. The J Heart Lung Transplant. 2015;34(3):369-75. PMID: 25444370. https://doi.org/10.1016/j.healun.2014.09.008
  15. Madani M.M. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the- art 2020. Pulm Circ. 2021;11(2):20458940211007372. PMID: 34104418; PMCID: PMC8150486. https://doi.org/10.1177/20458940211007372
  16. Yang J., Madani M.M., Mahmud E., Kim N.H. Evaluation and management of chronic thromboembolic pulmonary hypertension. Chest. 2023;164(2):490-502. PMID: 36990148. PMCID: PMC10410247. https://doi.org/10.1016/j.chest.2023.03.029
  17. Rivera-Lebron B., McDaniel M., Ahrar K., Alrifai A., Dudzinski D.M., Fanola C., Blais D., Janicke D., Melamed R., Mohrien K., Rozycki E., Ross C.B., Klein A.J., Rali P., Teman N.R., Yarboro L., Ichinose E., Sharma A.M., Bartos J.A., Elder M., Keeling B., Palevsky H., Naydenov S., Sen P., Amoroso N., Rodriguez-Lopez J.M., Davis G.A., Rosovsky R., Rosenfield K., Kabrhel C., Horowitz J., Giri J.S., Tapson V., Channick R., PERT Consortium. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT Consortium. Clin App Thromb Hemost. 2019;1076029619853037. PMID: 31185730; PMCID: PMC6714903. https://doi.org/10.1177/1076029619853037
  18. Miyahara S., Schröder T.A., Wilkens H., Karliova I., Langer F., Kunihara T., Schäfers H.J. Long-term outcomes after pulmonary endarterectomy in 499 patients over a 20-year period. Ann Thorac Surg. 2021;111(5):1585-1592. PMID: 32949609. https://doi.org/10.1016/j.athoracsur.2020.06.122
  19. Kallonen J., Korsholm K., Bredin F., Corbascio M., Andersen M.J., Ilkjær L.B., Mellemkjær S., Sartipy U. Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Pulm Circ. 2022;12(2):e12093. PMID: 35795490; PMCID: PMC9248798. https://doi.org/10.1002/pul2.12093
  20. Hsieh W.C., Jansa P., Huang W.C., Nižnanský M., Omara M., Lindner J. Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis. J Thorac Cardiovasc Surg. 2018;156(3):1275-1287. PMID: 29903403. https://doi.org/10.1016/j.jtcvs.2018.04.110
  21. Бадоян А.Г., Гранкин Д.С., Крестьянинов О.В., Шарафутди- нов У.Ш., Манукян С.Н., Баранов А.А., Хелимский Д.А. Бал- лонная легочная ангиопластика у пациентов с хронической тромбоэмболической легочной гипертензией: непосредст- венные и отдаленные результаты. Патология кровообраще- ния и кардиохирургия. 2024;28(3):52–63. https://doi.org/10.21688/1681-3472-2024-3-52-63 Badoian A.G., Grankin D.S., Krestyaninov O.V., Sharafutdinov U.Sh., Manukian S.N., Baranov A.A., Khelimskii D.A. Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery.2024;28(3):52-63. (In Russ.) https://doi.org/10.21688/1681-3472-2024-3-52-63
  22. Sihag S., Le B., Witkin A.S., Rodriguez-Lopez J.M., Villavicencio M.A., Vlahakes G.J., Channick R.N., Wright C.D. Quantifying the learning curve for pulmonary thromboendarterectomy. J Cardiothorac Surg. 2017;12(1):121. PMID: 29284512; PMCID: PMC5747243. https://doi.org/10.1186/s13019-017-0686-1
  23. Ishida K., Kohno H., Matsuura K., Sugiura T., Sanada T.J., Naito A., Shigeta A., Suda R., Sekine A., Masuda M., Sakao S., Tanabe N., Tatsumi K., Matsumiya G. Impact of residual pulmonary hypertension on long‐term outcomes after pulmonary endarterectomy in the modern era. Pulm Circ. 2023;13(2):e12215. PMID: 37051490; PMCID: PMC10084236. https://doi.org/10.1002/pul2.12215
  24. Skoro‐Sajer N., Marta G., Gerges C., Hlavin G., Nierlich P., Taghavi S., Sadushi‐Kolici R., Klepetko W., Lang I.M. Surgical specimens, haemodynamics and long‐term outcomes after pulmonary endarterectomy. Thorax. 2014;69(2):116-22. PMID: 24052543; PMCID: PMC3913220. https://doi.org/10.1136/thoraxjnl-2013-203746
  25. Guth S., D’Armini A.M., Delcroix M., Nakayama K., Fade E., Hoole S.P., Jenkins D.P., Kiely D.G., Kim N.H., Lang I.M., Madani M.M., Matsubara H., Ogawa A., Ota-Arakaki J.S., Quarck R., Sadushi-Kolici R., Simonneau G., Wiedenroth C.B., Yildizeli B.,Mayer E., Pepke-Zaba J. Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Res. 2021;7(3):00850-2020. PMID: 34409094; PMCID: PMC8365143. https://doi.org/10.1183/23120541.00850-2020
  26. Чернявский А.М., Едемский А.Г., Новикова Н.В., Гранкин Д.С., Кливер Е.Н., Гуля М.О., Дерягин М.Н., Завадовский К.В., Ка- менская О.В., Корнилов И.А., Нарциссова Г.П., Пак Н.Т., Ро-манов А.Б., под общ. ред. Чернявского А.М. Хирургическое лечение хронической тромбоэмболической легочной гипер- тензии. ФГБУ «НМИЦ им. ак. Е.Н. Мешалкина» Минздрава Рос- сии. Новосибирск: Изд-во СО РАН, 2019. С. 26–34. Chernyavskiy A.M., Edemskiy A.G., Novikova N.V., Grankin D.S., Kliver E.N., Gulya M.O., Deryagin M.N., Zavadovskiy K.V., Kamenskaya O.V., Kornilov I.A., Narcissova G.P., Pak N.T., Romanov A.B.; under the general editorship of Chernyavskiy A.M. Surgical treatment of chronic thromboembolic pulmonary hypertension. “Academician E.N. Meshalkin National Medical Research Center” of the Ministry of Health of Russia. Novosibirsk: Publishing House of the Siberian Branch of the Russian Academy of Sciences, 2019. P. 26–34. (In Russ.)
  27. Duan A., Li X., Jin Q., Zhang Y., Zhao Z., Zhao Q., Yan L., Huang Z., Hu M., Liu J., An C., Ma X., Xiong C., Luo Q., Liu Z. Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension. Therapeutic Adv Chronic Dis. 2022;13:20406223221102803. PMID: 35757779. PMCID: PMC9218458. https://doi.org/10.1177/20406223221102803
  28. Papamatheakis D.G., Poch D.S., Fernandes T.M., Kerr K.M., Kim N.H., Fedullo P.F. Chronic thromboembolic pulmonary hypertension: JACC focus seminar. J Am Coll Cardiol. 2020;76(18):2155–2169. PMID: 33121723. https://doi.org/10.1016/j.jacc.2020.08.074
  29. Kallonen J., Glaser N., Bredin F., Corbascio M., Sartipy U. Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single‐ center study. Pulm. Circ. 2020;10(2):2045894020918520. PMID: 32313643; PMCID: PMC7158258. https://doi.org/10.1177/2045894020918520
  30. Otani N., Watanabe R., Tomoe T., Toyoda S., Yasu T., Nakamoto T. Pathophysiology and treatment of chronic thromboembolic pulmonary hypertension. Int J Mol Sci. 2023;24(4):3979. PMID: 36835383; PMCID: PMC9968103. https://doi.org/10.3390/ijms24043979
  31. Deng L., Quan R., Yang Y., Yang Z., Tian H., Li S., Shen J., Ji Y., Zhang G., Zhang C., Wang G., Liu Y., Cheng Z., Yu Z., Song Z., Zheng Z., Cui W., Chen Y., Liu S., Xiong C., Shan G., He J. Characteristics and long-term survival of patients with chronic thromboembolic pulmonary hypertension in China. Respirology. 2021;26(2):196-203. PMID: 32954622. https://doi.org/10.1111/resp.13947
  32. Pang W., Zhang Z., Wang Z., Zhen K., Zhang M., Zhang Y., Gao Q., Zhang S., Tao X., Wan J., Xie W., Zhai Z. Higher incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism in Asians than in Europeans: a meta- analysis. Front Med. 2021;8:721294. PMID: 34765615; PMCID: PMC8575791. https://doi.org/10.3389/fmed.2021.721294
  33. Robbins I.M., Pugh M.E., Hemnes A.R. Update on chronic thromboembolic pulmonary hypertension. Trends Cardiovasc Med. 2017;27(1):29-37. PMID: 27345156. https://doi.org/10.1016/j.tcm.2016.05.010
  34. Pepke-Zaba J., Delcroix M., Lang I., Mayer E., Jansa P., Ambroz D., Treacy C., D’Armini A.M., Morsolini M., Snijder R., Bresser P., Torbicki A., Kristensen B., Lewczuk J., Simkova I., Barberà J.A.,de Perrot M., Hoeper M.M., Gaine S., Speich R., Gomez- Sanchez M.A., Kovacs G., Hamid A.M., Jaïs X., Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973-81. PMID: 21969018. https://doi.org/10.1161/CIRCULATIONAHA.110.015008
  35. Bhakta N.R., McGowan A., Ramsey K.A., Borg B., Kivastik J., Knight S.L., Sylvester K., Burgos F., Swenson E.R., McCarthy K., Cooper B.G., García-Río F., Skloot G., McCormack M., Mottram C., Irvin C.G., Steenbruggen I., Coates A.L., Kaminsky D.A. European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update. Eur Respir J. 2023;62(4):2201519. PMID: 37500112. https://doi.org/10.1183/13993003.01519-2022
  36. Чазова И.Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Акчурин Р.С., Аншелес А.А., Васильцева О.Я., Веселова Т.Н., Галявич А.С., Горбачевский С.В., Данилов Н.М., Едемский А.Г., Зелвеян П.А., Лазарева И.В., Матчин Ю.Г., Мершин К.В., Му- каров М.А., Наконечников С.Н., Саидова М.А., Сарыбаев А.Ш., Сергиенко В.Б., Стукалова О.В., Филиппов Е.В., Черняв- ский А.М., Чернявский М.А., Шалаев С.В., Шмальц А.А. Евразийские рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (2020). Евразийский кардиологический журнал. 2021;(1):6-43. https://doi.org/10.38109/2225-1685-2021-1-6-43 Chazova I.E., Martynyuk T.V., Valieva Z.S., Azizov V.A., Akchurin R.S., Ansheles A.A., Vasiltseva O.Ya., Veselova T.N., Galyavich A.S., Gorbachevsky S.V., Danilov N.M., Edemskiy A.G., Parunak A. Zelveyan P.A., Lazareva I.V., Matchin Yu.G., Mershin K.V., Mukarov M.A., Nakonechnikov S.N., Saidova M.A., Sarybaev A.Sh., Sergienko V.B., Stukalova O.V., Filippov E.V., Chernyavsky A.M., Chernyavsky M.A., Sharia M.A., Shalaev S.V., Shmalts A.A. Eurasian Guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (2020). Eurasian Heart Journal. 2021;(1):6-43. (In Russ.) https://doi.org/10.38109/2225-1685-2021-1-6-43
  37. Skoro-Sajer N., Hack N., Sadushi-Koliçi R., Bonderman D., Jakowitsch J., Klepetko W., Hoda M.A., Kneussl M.P., Fedullo P., Lang I.M. Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study. Circulation. 2009;119(2):298-305. PMID: 19118254. https://doi.org/10.1161/CIRCULATIONAHA.108.794610
  38. Рагино Ю.И., Каштанова Е.В., Полонская Я.В., Стахнева Е.М. Биомолекулы абдоминального ожирения. Новосибирск: На- ука, 2023. 152 с. Ragino Yu.I., Kashtanova E.V., Polonskaya Ya.V., Stakhneva E.M. Biomolecules of abdominal obesity. Novosibirsk: Nauka, 2023. 152 p. (In Russ.)
  39. Логинова И.Ю., Каменская О.В., Чернявский А.М., Ломиворо- тов В.В. Хроническая обструктивная болезнь легких как пре- диктор неблагоприятного прогноза хирургического лечения хронической тромбоэмболической легочной гипертензии. Пульмонология. 2016;26(6):694-700. https://doi.org/10.18093/0869-0189-2016-26-6-694-700 Loginova I.Yu., Kamenskaya O.V., Chernyavskiy A.M., Lomivorotov V.V. Chronic obstructive pulmonary disease as a predictor of poor outcome of surgery for chronic thromboembolic pulmonary hypertension. Russian Pulmonology. 2016;26(6):694-700. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-6-694-700
  40. Гематология: национальное руководство / под ред. О.А. Рука- вицына. М.: ГЭОТАР-Медиа, 2017. 784 с. Hematology: national guide / ed. by O.A. Rukavitsyn. Moscow: GEOTAR-Media, 2017. 784 p. (In Russ.)